MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development?

Kenneth Maiese1

  • 1Cellular and Molecular Signaling, Newark, New Jersey 07101, USA.

Journal of Translational Science
|November 13, 2015
PubMed

Insights

MicroRNAs regulate stem cell renewal and differentiation by influencing SIRT1 and autophagy pathways. Targeting these microRNAs shows therapeutic potential but faces challenges for clinical application.

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Genetics

Background:

  • Small non-coding RNAs, microRNAs (miRNAs), are key regulators of cellular processes.
  • miRNAs influence stem cell renewal, differentiation, and disease progression.
  • SIRT1 and mTOR-autophagy pathways are critical for stem cell proliferation and survival.

Purpose of the Study:

  • To explore the role of miRNAs in regulating stem cell renewal and differentiation.
  • To investigate the interplay between miRNAs, SIRT1, and mTOR-mediated autophagy.
  • To assess the therapeutic potential and challenges of targeting miRNAs for clinical applications.

Main Methods:

  • Review of current literature on miRNA function in stem cells.
  • Analysis of the molecular mechanisms linking miRNAs to SIRT1 and autophagy.
  • Discussion of translational challenges in manipulating non-coding RNAs for therapeutic benefit.

Main Results:

  • miRNAs significantly impact stem cell fate decisions.
  • miRNA regulation of SIRT1 and mTOR-autophagy pathways is crucial for stem cell behavior.
  • Targeting specific miRNAs offers potential for treating various disorders.

Conclusions:

  • miRNAs are critical regulators of stem cell renewal and differentiation.
  • The interplay between miRNAs, SIRT1, and autophagy presents therapeutic opportunities.
  • Overcoming challenges in miRNA-based therapies is essential for successful clinical translation.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K